Crossmark

Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use

Crossref DOI link: https://doi.org/10.1186/s12954-018-0255-5

Published Online: 2018-09-21

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Curtis, Michael http://orcid.org/0000-0002-1814-0867
Dietze, Paul

Aitken, Campbell

Kirwan, Amy

Kinner, Stuart A.

Butler, Tony

Stoové, Mark
Funding

Funding for this research was provided by:

National Health and Medical Research Council (APP1029915, APP1078168, APP136908)

National Health and Medical Research Council (APP1090445)

We gratefully acknowledge the support provided to the Burnet Institute by the Victorian Government Operational Infrastructure Support Program
License Information

Text and Data Mining valid from 2018-09-21
More Information

Article History

Received: 27 June 2018

Accepted: 7 September 2018

First Online: 21 September 2018

Ethics approval and consent to participate

: Ethics approval for the Prison and Transition Health Cohort Study was obtained from the Alfred Hospital Human Research Ethics Committee (79/12) and the Victorian Department of Justice Human Research Ethics Committee (CF/14/10169). All participants provided informed, written consent prior to participation.

: Not applicable.

: PD and MS have received investigator-initiated funding from Gilead Sciences and PD has received an untied educational grant from Indivior for work unrelated to this study. PD, SK and MS are NHMRC Senior Research Fellows<i>.</i> The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.